Eli Lilly in Ireland released a statement reporting that the Minister for Jobs, Enterprise and Innovation Richard Bruton TD announced that Eli Lilly and Company, a global leader biopharmaceuticals, is to invest €330 million in a brand-new facility at its Kinsale campus.
The investment will lead to the creation of 200 new jobs at the facility, as well as a further 300 construction jobs which will be created as part of the building works. This will bring Eli Lilly’s total employment in Ireland up to almost 1,000.
The investment will expand the Kinsale site’s existing biopharmaceutical mission with the establishment of an additional world-class commercialisation and manufacturing facility.
The planned 240,000-square-foot biopharmaceutical commercialisation and manufacturing facility will further enhance the company’s ability to bring treatments for illnesses such as cancer and diabetes to patients worldwide
“This investment is an endorsement of the Lilly Kinsale site’s success in developing a biopharmaceutical business in recent years and demonstrates our ability to rise to that challenge. This is in no small part due to the site’s excellent performance record, the talent of the workforce, and the support from IDA Ireland,” said Ed Canary, general manager of the Kinsale site.
Follow us on Twitter @CKClinical to receive more industry news and CK jobs of the week updates